BioMarin Pharmaceutical Inc. (BMRN)
NASDAQ: BMRN · Real-Time Price · USD
62.56
+0.59 (0.95%)
Nov 20, 2024, 4:00 PM EST - Market closed

BioMarin Pharmaceutical Stock Forecast

Stock Price Forecast

The 20 analysts with 12-month price forecasts for BMRN stock have an average target of 94.2, with a low estimate of 65 and a high estimate of 122. The average target predicts an increase of 50.58% from the current stock price of 62.56.

Analyst Consensus: Buy
Target Low Average Median High
Price $65 $94.2 $90 $122
Change +3.90% +50.58% +43.86% +95.01%

Analyst Ratings

The average analyst rating for BMRN stock from 21 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 545655
Buy 77891010
Hold 986666
Sell 000000
Strong Sell 000000
Total 211919212121

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Wolfe Research
Wolfe Research
Buy
Initiates
$95
Buy Initiates $95 +51.85% Nov 15, 2024
Citigroup
Citigroup
Hold
Maintains
$93$81
Hold Maintains $93$81 +29.48% Oct 30, 2024
Canaccord Genuity
Canaccord Genuity
Hold
Maintains
$93$84
Hold Maintains $93$84 +34.27% Oct 30, 2024
Cantor Fitzgerald
Cantor Fitzgerald
Buy
Maintains
$110$90
Buy Maintains $110$90 +43.86% Oct 30, 2024
JP Morgan
JP Morgan
Buy
Maintains
$110$109
Buy Maintains $110$109 +74.23% Oct 30, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
2.87B
from 2.42B
Increased by 18.72%
Revenue Next Year
3.15B
from 2.87B
Increased by 9.64%
EPS This Year
2.09
from 0.87
Increased by 140.78%
EPS Next Year
3.05
from 2.09
Increased by 45.69%
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
1.70B1.86B1.85B2.10B2.42B2.87B3.15B3.47B
Revenue Growth
14.27%9.18%-0.76%13.53%15.42%18.72%9.64%10.07%
EPS
-0.134.50-0.350.750.872.093.054.06
EPS Growth
----16.00%140.78%45.69%32.98%
Forward PE
-----29.8620.5015.42
No. Analysts -----323126
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 3.0B 3.4B 3.9B
Avg 2.9B 3.1B 3.5B
Low 2.7B 2.8B 2.7B

Revenue Growth

Revenue Growth 20242025202620272028
High
23.6%
19.2%
23.8%
Avg
18.7%
9.6%
10.1%
Low
9.7%
-2.2%
-13.6%

EPS Forecast

EPS 20242025202620272028
High 2.41 4.10 6.22
Avg 2.09 3.05 4.06
Low 1.81 1.77 1.08

EPS Growth

EPS Growth 20242025202620272028
High
176.9%
95.5%
103.7%
Avg
140.8%
45.7%
33.0%
Low
108.4%
-15.3%
-64.7%
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.